411 results on '"Mitjà, Oriol"'
Search Results
152. Malaria epidemiology in Lihir Island, Papua New Guinea
- Author
-
Mitjà, Oriol, primary, Paru, Raymond, additional, Selve, Billy, additional, Betuela, Inoni, additional, Siba, Peter, additional, De Lazzari, Elisa, additional, and Bassat, Quique, additional
- Published
- 2013
- Full Text
- View/download PDF
153. Yaws
- Author
-
Mitjà, Oriol, primary, Asiedu, Kingsley, additional, and Mabey, David, additional
- Published
- 2013
- Full Text
- View/download PDF
154. Haemophilus ducreyi: from sexually transmitted infection to skin ulcer pathogen.
- Author
-
Lewis, David A. and Mitjà, Oriol
- Published
- 2016
- Full Text
- View/download PDF
155. Epidemiology of Haemophilus ducreyi Infections.
- Author
-
González-Beiras, Camila, Marks, Michael, Chen, Cheng Y., Roberts, Sally, and Mitjà, Oriol
- Subjects
EPIDEMIOLOGY ,HAEMOPHILUS ducreyi ,HAEMOPHILUS diseases ,MICROBIOLOGY ,DIAGNOSIS ,SKIN ulcers ,CHANCROID ,HAEMOPHILUS ,RESEARCH funding - Abstract
The global epidemiology of Haemophilus ducreyi infections is poorly documented because of difficulties in confirming microbiological diagnoses. We evaluated published data on the proportion of genital and nongenital skin ulcers caused by H. ducreyi before and after introduction of syndromic management for genital ulcer disease (GUD). Before 2000, the proportion of GUD caused by H. ducreyi ranged from 0.0% to 69.0% (35 studies in 25 countries). After 2000, the proportion ranged from 0.0% to 15.0% (14 studies in 13 countries). In contrast, H. ducreyi has been recently identified as a causative agent of skin ulcers in children in the tropical regions; proportions ranged from 9.0% to 60.0% (6 studies in 4 countries). We conclude that, although there has been a sustained reduction in the proportion of GUD caused by H. ducreyi, this bacterium is increasingly recognized as a major cause of nongenital cutaneous ulcers. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
156. Mycetoma Caused by Nocardia yamanashiensis, Papua New Guinea
- Author
-
Mitjà, Oriol, primary, Van Straten, Christian, additional, Hays, Russell, additional, Bassat, Quique, additional, Robson, Jenny, additional, and Koka, Murray, additional
- Published
- 2012
- Full Text
- View/download PDF
157. HMS-Related Hemolysis after Acute Attacks of Plasmodium vivax Malaria
- Author
-
Mitjà, Oriol, primary, Robson, Jenny, additional, Hays, Russell, additional, Ipai, Anthony, additional, Malken, James, additional, Bassat, Quique, additional, and Kangapu, Samson, additional
- Published
- 2011
- Full Text
- View/download PDF
158. The Impact of a Filariasis Control Program on Lihir Island, Papua New Guinea
- Author
-
Mitjà, Oriol, primary, Paru, Raymond, additional, Hays, Russell, additional, Griffin, Lysaght, additional, Laban, Nedley, additional, Samson, Mellie, additional, and Bassat, Quique, additional
- Published
- 2011
- Full Text
- View/download PDF
159. Challenges in Recognition and Diagnosis of Yaws in Children in Papua New Guinea
- Author
-
Mitjà, Oriol, primary, Pakarui, Slim, additional, Lelngei, Francis, additional, Laban, Nedley, additional, Bassat, Quique, additional, Hays, Russell, additional, and Ipai, Anthony, additional
- Published
- 2011
- Full Text
- View/download PDF
160. Outcome Predictors in Treatment of Yaws
- Author
-
Mitjà, Oriol, primary, Hays, Russell, additional, Ipai, Anthony, additional, Gubaila, David, additional, Lelngei, Francis, additional, Kirara, Martin, additional, Paru, Raymond, additional, and Bassat, Quique, additional
- Published
- 2011
- Full Text
- View/download PDF
161. Haemophilus ducreyi DNA is detectable on the skin of asymptomatic children, flies and fomites in villages of Papua New Guinea
- Author
-
Houinei, Wendy, Godornes, Charmie, Kapa, August, Knauf, Sascha, Mooring, Eric Q., González-Beiras, Camila, Watup, Ronald, Paru, Raymond, Advent, Paul, Bieb, Sivauk, Sanz, Sergi, Bassat, Quique, Spinola, Stanley M., Lukehart, Sheila A., and Mitjà, Oriol
- Subjects
Medicine and Health Sciences ,Diagnostic Medicine ,Signs and Symptoms ,Ulcers ,Pathology and Laboratory Medicine ,Biology and Life Sciences ,Molecular Biology ,Molecular Biology Techniques ,Artificial Gene Amplification and Extension ,Polymerase Chain Reaction ,Infectious Diseases ,Bacterial Diseases ,Treponematoses ,Yaws ,Tropical Diseases ,Neglected Tropical Diseases ,Dermatology ,Skin Infections ,Microbiology ,Medical Microbiology ,Microbial Pathogens ,Bacterial Pathogens ,Treponema Pallidum ,Pathogens ,Bacteriology ,Gram Negative Bacteria ,Extraction techniques ,DNA extraction ,Organisms ,Bacteria ,Haemophilus - Abstract
Background: Haemophilus ducreyi and Treponema pallidum subsp. pertenue are major causes of leg ulcers in children in Africa and the Pacific Region. We investigated the presence of DNA (PCR positivity) from these bacteria on asymptomatic people, flies, and household linens in an endemic setting. Methodology/Principal findings We performed a cross-sectional study in rural villages of Lihir Island, Papua New Guinea during a yaws elimination campaign. Participants were asymptomatic subjects recruited from households with cases of leg ulcers, and from households without cases of leg ulcers. We rubbed swabs on the intact skin of the leg of asymptomatic individuals, and collected flies and swabs of environmental surfaces. All specimens were tested by PCR for H. ducreyi and T. p. pertenue DNA. Of 78 asymptomatic participants that had an adequate specimen for DNA detection, H. ducreyi-PCR positivity was identified in 16 (21%) and T. p. pertenue-PCR positivity in 1 (1%). In subgroup analyses, H. ducreyi-PCR positivity did not differ in participants exposed or not exposed to a case of H. ducreyi ulcer in the household (24% vs 18%; p = 0.76). Of 17 cultures obtained from asymptomatic participants, 2 (12%) yielded a definitive diagnosis of H. ducreyi, proving skin colonization. Of 10 flies tested, 9 (90%) had H. ducreyi DNA and 5 (50%) had T. p. pertenue DNA. Of 6 bed sheets sampled, 2 (33%) had H. ducreyi DNA and 1 (17%) had T. p. pertenue DNA. Conclusions/Significance: This is the first time that H. ducreyi DNA and colonization has been demonstrated on the skin of asymptomatic children and that H. ducreyi DNA and T. p. pertenue DNA has been identified in flies and on fomites. The ubiquity of H. ducreyi in the environment is a contributing factor to the spread of the organism.
- Published
- 2017
- Full Text
- View/download PDF
162. Case Report: Yaws Osteoperiostitis Treated with Single-Dose Azithromycin.
- Author
-
González-Beiras, Camila, Vall-Mayans, Martí, González-Escalante, Ángel, McClymont, Kelly, Li Ma, and Mitjà, Oriol
- Published
- 2017
- Full Text
- View/download PDF
163. Epidemiology of yaws: an update.
- Author
-
Kazadi, Walter M., Asiedu, Kingsley B., Agana, Nsiire, and Mitjà, Oriol
- Subjects
YAWS ,TROPICAL medicine ,EPIDEMIOLOGY ,INFECTIOUS disease transmission ,DISEASE prevalence ,DISEASE eradication - Abstract
Yaws, a neglected tropical disease, is targeted for eradication by 2020 through large-scale mass-treatment programs of endemic communities. A key determinant for the success of the eradication campaign is good understanding of the disease epidemiology. We did a review of historical trends and new information from endemic countries, with the aim of assessing the state of knowledge on yaws disease burden. Transmission of yaws is now present in Africa, Asia, and the South Pacific. At least 12 countries are known to harbor yaws cases and 21 to 42 million people live in endemic areas. Between 2008 and 2012 more than 300,000 new cases were reported to the World Health Organization. Yaws presented high geographical variation within a country or region, high seasonality for incidence of active disease, and evidence that low standards of hygiene predispose to suffering of the disease. Key data issues include low levels of reporting, potential misdiagnosis, and scarce documentation on prevalence of asymptomatic infections. Currently available data most likely underestimates the magnitude of the disease burden. More effort is needed in order to refine accuracy of data currently being reported. A better characterization of the epidemiology of yaws globally is likely to positively impact on planning and implementation of yaws eradication. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
164. New Treatment Schemes for Yaws: The Path Toward Eradication.
- Author
-
Mitjà, Oriol, Hays, Russell, Rinaldi, Andrea C., McDermot, Robyn, and Bassat, Quique
- Subjects
- *
YAWS , *AZITHROMYCIN , *DRUG dosage , *PHARMACODYNAMICS , *BACTERIAL disease transmission , *FEASIBILITY studies , *THERAPEUTICS - Abstract
Yaws—a nonvenereal treponemal infection—can be cured with an oral single dose of azithromycin. New strategies, such as mass treatment with this antibiotic, might be effective to interrupt transmission. Eradication is now considered biologically feasible and programmatically attainable. [ABSTRACT FROM PUBLISHER]
- Published
- 2012
- Full Text
- View/download PDF
165. Osteoperiostitis in Early Yaws: Case Series and Literature Review.
- Author
-
Mitjà, Oriol, Hays, Russell, Ipai, Anthony, Wau, Bonnie, and Bassat, Quique
- Subjects
- *
MEDICAL radiology , *LITERATURE reviews , *HEALTH outcome assessment , *OSTEITIS , *SHIN splints , *PENICILLIN ,DIAGNOSIS of bone diseases - Abstract
We describe the clinical and radiological manifestations and outcome after treatment of 7 children who received a diagnosis of early yaws osteoperiostitis. Osteoperiostitis occurred some weeks after the primary infection, and the most common finding was hypertrophic periostitis of long bones. All treated patients had excellent responses to benzyl-penicillin therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
166. Short Report : HMS-Related Hemolysis after Acute Attacks of Plasmodium vivax Malaria.
- Author
-
Mitjà, Oriol, Hays, Russell, Malken, James, Ipai, Anthony, Kangapu, Samson, Robson, Jenny, and Bassat, Quique
- Published
- 2011
- Full Text
- View/download PDF
167. Streptococcus pyogenesIs Associated with Idiopathic Cutaneous Ulcers in Children on a Yaws-Endemic Island
- Author
-
Griesenauer, Brad, González-Beiras, Camila, Fortney, Katherine R., Lin, Huaiying, Gao, Xiang, Godornes, Charmie, Nelson, David E., Katz, Barry P., Lukehart, Sheila A., Mitjà, Oriol, Dong, Qunfeng, and Spinola, Stanley M.
- Abstract
Cutaneous ulcers (CU) affect approximately 100,000 children in the tropics each year. While two-thirds of CU are caused by Treponema pallidumsubspecies pertenueand Haemophilus ducreyi, the cause(s) of the remaining one-third is unknown.
- Published
- 2021
- Full Text
- View/download PDF
168. Metaanalysis of the Performance of a Combined Treponemal and Nontreponemal Rapid Diagnostic Test for Syphilis and Yaws
- Author
-
Marks, Michael, Yin, Yue-Ping, Chen, Xiang-Sheng, Castro, Arnold, Causer, Louise, Guy, Rebecca, Wangnapi, Regina, Mitjà, Oriol, Aziz, Abdul, Castro, Rita, da Luz Martins Pereira, Filomena, Taleo, Fasihah, Guinard, Jérôme, Bélec, Laurent, Tun, Ye, Bottomley, Christian, Ballard, Ronald C., and Mabey, David C.W.
- Subjects
Sexually transmitted diseases ,Models, Statistical ,Sífilis ,syphilis ,yaws ,Reproducibility of Results ,Sensitivity and Specificity ,Point-of-Care Testing ,parasitic diseases ,Humans ,point-of-care test ,Reagent Kits, Diagnostic ,Syphilis ,Malalties de transmissió sexual ,Articles and Commentaries ,sexually transmitted infections ,metaanalysis - Abstract
A combined treponemal and nontreponemal rapid diagnostic test was found to have good sensitivity and specificity for both syphilis and yaws. The performance of both the treponemal and nontreponemal test components was strongly associated with the rapid plasma reagin titer., Background. The human treponematoses are important causes of disease. Mother-to-child transmission of syphilis remains a major cause of stillbirth and neonatal death. There are also almost 100 000 cases of endemic treponemal disease reported annually, predominantly yaws. Rapid diagnostic tests (RDTs) would improve access to screening for these diseases. Most RDTs cannot distinguish current and previous infection. The Dual Path Platform (DPP) Syphilis Screen & Confirm test includes both a treponemal (T1) and nontreponemal (T2) component and may improve the accuracy of diagnosis. Methods. We conducted a metaanalysis of published and unpublished evaluations of the DPP-RDT for the diagnosis of syphilis and yaws. We calculated the sensitivity, specificity, and overall agreement of the test compared with reference laboratory tests. Results. Nine evaluations, including 7267 tests, were included. Sensitivity was higher in patients with higher titer rapid plasma reagin (≥1:16) for both the T1 (98.2% vs 90.1%, P < .0001) and the T2 component (98.2% vs 80.6%, P < .0001). Overall agreement between the DPP test and reference serology was 85.2% (84.4%–86.1%). Agreement was highest for high-titer active infection and lowest for past infection. Conclusions. The RDT has good sensitivity and specificity of the treponemal and nontreponemal components both in cases of suspected syphilis and yaws, although the sensitivity is decreased at lower antibody titers.
169. Yaws
- Author
-
Marks, Michael, Mitjà, Oriol, Solomon, Anthony W., Asiedu, Kingsley B., Mabey, David C., Marks, Michael, Mitjà, Oriol, Solomon, Anthony W., Asiedu, Kingsley B., and Mabey, David C.
- Abstract
Introduction Yaws, caused by Treponema pallidum ssp. pertenue, is endemic in parts of West Africa, Southeast Asia and the Pacific. The WHO has launched a campaign based on mass treatment with azithromycin, to eradicate yaws by 2020. Sources of data We reviewed published data, surveillance data and data presented at yaws eradication meetings. Areas of agreement Azithromycin is now the preferred agent for treating yaws. Point-of-care tests have demonstrated their value in yaws. Areas of controversy There is limited data from 76 countries, which previously reported yaws. Different doses of azithromycin are used in community mass treatment for yaws and trachoma. Growing points Yaws eradication appears an achievable goal. The programme will require considerable support from partners across health and development sectors. Areas timely for developing research Studies to complete baseline mapping, integrate diagnostic tests into surveillance and assess the impact of community mass treatment with azithromycin are ongoing
170. Mpox in people with past infection or a complete vaccination course: a global case series.
- Author
-
Hazra, Aniruddha, Zucker, Jason, Bell, Elizabeth, Flores, John, Gordon, Leanna, Mitjà, Oriol, Suñer, Clara, Lemaignen, Adrien, Jamard, Simon, Nozza, Silvia, Nori, Achyuta V, Pérez-Barragán, Edgar, Rodríguez-Aldama, Juan Carlos, Blanco, Jose Louis, Delaugerre, Constance, Turner, Dan, Fuertes, Irene, Leiro, Viviana, Walmsley, Sharon L, and Orkin, Chloe M
- Subjects
- *
MONKEYPOX , *SEXUALLY transmitted diseases , *VACCINATION , *BISEXUAL men , *NATURAL immunity - Abstract
Since May, 2022, a large global outbreak of human mpox (formerly known as monkeypox) has predominantly affected men who have sex with men. The strain responsible, Clade IIb, has mutated substantially from precursors originating from the 2017–18 outbreak in Nigeria. Immunity to smallpox, another orthopoxvirus, via previous infection or vaccination provides lifelong immunity. However, since the 2022 mpox outbreak, recent clusters were described in individuals with presumed immunity through recent infection or vaccination. We aim to describe the epidemiological and clinical characteristics of mpox in individuals with past infection or vaccination to improve the understanding of this disease in the setting of previous immunity. In this global case series, international collaborators from nine countries provided data on individuals with PCR-confirmed mpox after documented previous infection or vaccination between May 11, 2022, and June 30, 2023. We excluded cases that could not confirm vaccination status or cases with partial immunisation or any doses received before the current multi-national mpox outbreak (cutoff date May 1, 2022). Data were collected via a case report spreadsheet that reported on dates of infection and vaccination, route of immunisation, demographic characteristics, clinical findings, HIV status, concomitant sexually transmitted infections, and markers of disease severity (mpox severity score system). We describe case epidemiology, clinical course, and mpox severity scores; all analyses were descriptive. We report mpox infections in 37 gay and bisexual men who have sex with men: seven individuals had mpox reinfections, 29 individuals had mpox infections that occurred after two appropriately spaced Modified Vaccinia Ankara-Bavarian Nordic vaccine courses, and one individual had an infection that met the criteria for both reinfection and infection after vaccination. The median age of individuals was 36 years (IQR 30–45; range 21–58). Those with natural immunity after initial infection had a shorter disease course with less mucosal disease upon reinfection than with their initial infection. Infections post-vaccination were characterised by few lesions, little mucosal disease, and minimal analgesia requirements; two people received oral tecovirimat. Overall, there were no deaths, no bacterial superinfections, and all individuals were managed in the ambulatory clinic with one hospital admission for a necrotising neck lesion. The epidemiology of people with mpox reinfection or infection post-vaccination was similar to other published cohorts during the 2022 outbreak—predominantly young, sexually active gay and bisexual men who have sex with men. Clinical features and outcomes of repeat infection and infection after vaccination appear to be less clinically severe than those described in 2022 case literature. Specifically, compared with the 2022 case series, these individuals in the present study had fewer confluent lesions, less mucosal involvement, reduced analgesia requirement, and fewer admissions. Natural immunity and vaccine-induced immunity are not fully protective against mpox infection. However, in this small series both disease duration and severity appear to be reduced. None. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
171. Mass Treatment with Single-Dose Azithromycin for Yaws.
- Author
-
Mitjà, Oriol, Lukehart, Sheila, and Bassat, Quique
- Abstract
A response from the author of the article "Mass treatment with single-dose azithromycin for yaws" in the February 19, 2015 issue is presented.
- Published
- 2016
- Full Text
- View/download PDF
172. Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials.
- Author
-
Levine, Adam C, Fukuta, Yuriko, Huaman, Moises A, Ou, Jiangda, Meisenberg, Barry R, Patel, Bela, Paxton, James H, Hanley, Daniel F, Rijnders, Bart J A, Gharbharan, Arvind, Rokx, Casper, Zwaginga, Jaap Jan, Alemany, Andrea, Mitjà, Oriol, Ouchi, Dan, Millat-Martinez, Pere, Durkalski-Mauldin, Valerie, Korley, Frederick K, Dumont, Larry J, and Callaway, Clifton W
- Subjects
- *
MEDICAL databases , *RELATIVE medical risk , *META-analysis , *MEDICAL information storage & retrieval systems , *CONFIDENCE intervals , *IMMUNOGLOBULINS , *SYSTEMATIC reviews , *PREVENTIVE health services , *CONVALESCENT plasma , *HOSPITAL care , *DESCRIPTIVE statistics , *MEDLINE , *COVID-19 pandemic , *OUTPATIENT services in hospitals , *COMORBIDITY - Abstract
Background Outpatient monoclonal antibodies are no longer effective and antiviral treatments for coronavirus disease 2019 (COVID-19) disease remain largely unavailable in many countries worldwide. Although treatment with COVID-19 convalescent plasma (CCP) is promising, clinical trials among outpatients have shown mixed results. Methods We conducted an individual participant data meta-analysis from outpatient trials to assess the overall risk reduction for all-cause hospitalizations by day 28 in transfused participants. Relevant trials were identified by searching Medline, Embase, medRxiv, World Health Organization COVID-19 Research Database, Cochrane Library, and Web of Science from January 2020 to September 2022. Results Five included studies from 4 countries enrolled and transfused 2620 adult patients. Comorbidities were present in 1795 (69%). The virus neutralizing antibody dilutional titer levels ranged from 8 to 14 580 in diverse assays. One hundred sixty of 1315 (12.2%) control patients were hospitalized, versus 111 of 1305 (8.5%) CCP-treated patients, yielding a 3.7% (95% confidence interval [CI], 1.3%–6.0%; P =.001) absolute risk reduction and 30.1% relative risk reduction for all-cause hospitalization. The hospitalization reduction was greatest in those with both early transfusion and high titer with a 7.6% absolute risk reduction (95% CI, 4.0%–11.1%; P =.0001) accompanied by at 51.4% relative risk reduction. No significant reduction in hospitalization was seen with treatment >5 days after symptom onset or in those receiving CCP with antibody titers below the median titer. Conclusions Among outpatients with COVID-19, treatment with CCP reduced the rate of all-cause hospitalization and may be most effective when given within 5 days of symptom onset and when antibody titer is higher. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
173. Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis.
- Author
-
Alshehri, Abdullah, Chhonker, Yashpal S., Bala, Veenu, Edi, Constant, Bjerum, Catherine M., Koudou, Benjamin G., John, Lucy N., Mitjà, Oriol, Marks, Michael, King, Christopher L., and Murry, Daryl J.
- Subjects
- *
FILARIASIS , *DRUG administration , *PHARMACOKINETICS , *IVERMECTIN , *POISONS - Abstract
Background: Ivermectin (IVM) is a broad–spectrum anthelmintic drug used to treat diseases caused by filarial worms, such as onchocerciasis and lymphatic filariasis (LF). IVM is part of a triple–drug therapy used by the Mass Drug Administration (MDA) as a preventive strategy to eradicate LF in sub–Saharan Africa. The drug shows high variability in drug exposure in previous pharmacokinetic studies. This study aims to build a population pharmacokinetic (PopPK) model to identify and quantify the possible sources of the variability of IVM exposure after a single–oral dose in LF–infected subjects and healthy individuals. Methodology / Principal findings: In this analysis, 724 samples were collected from treatment–naïve Wuchereria bancrofti–infected (n = 32) and uninfected (n = 24) adults living in Côte d'Ivoire who had received one dose of IVM as a part of triple–drug therapy. PopPK analysis was conducted using Phoenix NLME 8.3 software. The Monte Carlo simulation based on the final model was performed to simulate drug exposure among different dosing groups (200 μg/kg, 18 mg, and 36 mg). A two–compartment model with zero–order dose input into the absorption compartment with a lag time function followed by first–order absorption and linear elimination best described the IVM's pharmacokinetic (PK) parameters. The final model identifies that the PK parameters of IVM are not affected by LF infection. Sex was a significant covariate on the peripheral volume of distribution (Vp/F, 53% lower in men than in women). IVM drug exposure shows linear pharmacokinetic behavior among the simulated dosing groups with similar drug exposure based on sex. Conclusion/Significance: We have developed a PopPk model to describe and identify possible sources of the variability of IVM exposure. To our knowledge, this is the first PopPK study of IVM in patients with LF. Trial registration: NCT02845713; NCT03664063 Author summary: Ivermectin has been shown to be a valuable tool in mass drug administration campaigns against lymphatic filariasis. The drug shows high variability in drug exposure in previous pharmacokinetic studies. Variability in drug exposure can lead to either a higher exposure with the potential for toxic effects or a lower exposure that may result in treatment failure. Identifying and quantifying the source of high variability using non–linear mixed effects modeling is crucial for future dosing recommendations that seek to maximize therapeutic benefit while minimizing toxicity risks. In this study, the variability of IVM exposure after a single oral dose was investigated with a population pharmacokinetic model using data from Lymphatic filariasis infected subjects and healthy individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
174. Two Streptococcus pyogenes emm types and several anaerobic bacterial species are associated with idiopathic cutaneous ulcers in children after community-based mass treatment with azithromycin.
- Author
-
Griesenauer, Brad, Ying, Xue, Fortney, Katherine R., Gao, Xiang, González-Beiras, Camila, Nelson, David E., Ren, Jie, Mitjà, Oriol, Dong, Qunfeng, and Spinola, Stanley M.
- Subjects
- *
TREPONEMA pallidum , *STREPTOCOCCUS pyogenes , *DISEASE eradication , *AZITHROMYCIN , *ULCERS , *ANAEROBIC bacteria , *NEGLECTED diseases - Abstract
Background: In yaws-endemic areas, two-thirds of exudative cutaneous ulcers (CU) are associated with Treponema pallidum subsp. pertenue (TP) and Haemophilus ducreyi (HD); one-third are classified as idiopathic ulcers (IU). A yaws eradication campaign on Lihir Island in Papua New Guinea utilizing mass drug administration (MDA) of azithromycin initially reduced but failed to eradicate yaws; IU rates remained constant throughout the study. Using 16S rRNA gene sequencing, we previously determined that Streptococcus pyogenes was associated with some cases of IU. Here, we applied shotgun metagenomics to the same samples we analyzed previously by 16S rRNA sequencing to verify this result, identify additional IU-associated microorganisms, and determine why S. pyogenes-associated IU might have persisted after MDA of azithromycin. Methodology/Principal findings: We sequenced DNA extracted from 244 CU specimens separated into four groups based upon microorganism-specific PCR results (HD+, TP+, TP+HD+, and TP-HD- or IU). S. pyogenes was enriched in IU (24.71% relative abundance [RA]) specimens compared to other ulcer sub-groups, confirming our prior results. We bioinformatically identified the emm (M protein gene) types found in the S. pyogenes IU specimens and found matches to emm156 and emm166. Only ~39% of IU specimens contained detectable S. pyogenes, suggesting that additional organisms could be associated with IU. In the sub-set of S. pyogenes-negative IU specimens, Criibacterium bergeronii, a member of the Peptostreptococcaceae, and Fusobacterium necrophorum (7.07% versus 0.00% RA and 2.18% versus 0.00% RA, respectively), were enriched compared to the S. pyogenes-positive sub-set. Although a broad range of viruses were detected in the CU specimens, none were specifically associated with IU. Conclusions/Significance: Our observations confirm the association of S. pyogenes with IU in yaws-endemic areas, and suggest that additional anaerobic bacteria, but not other microorganisms, may be associated with this syndrome. Our results should aid in the design of diagnostic tests and selective therapies for CU. Author summary: The World Health Organization classifies as a neglected tropical disease. It has been estimated that 100,000 children in 14 yaws-endemic countries develop cutaneous ulcers annually. The overall burden of infectious skin ulcers has not been determined and is likely to be much higher. Two-thirds of these ulcers are associated with Treponema pallidum subspecies pertenue and/or Haemophilus ducreyi, while the cause(s) of the remaining one-third are unknown. An ulcer eradication campaign on Lihir Island, Papua New Guinea, utilized mass drug administration of azithromycin and failed to fully eradicate ulcers in part due to the persistence of ulcers of unknown cause. By 16S rRNA gene sequencing, which only detects a subset of bacteria, we previously showed S. pyogenes was associated with skin ulcers of unknown origin. Here we applied direct DNA sequencing to identify other microorganisms present in these specimens. Confirming and extending our previous data, we found that Streptococcus pyogenes and several anaerobic bacteria were enriched in ulcers of unknown cause. We did not find enrichment of any viral or fungal microbes. Testing for S. pyogenes and selected anaerobes will help strengthen eradication efforts by improving diagnostic testing and treatment of this painful and debilitating syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
175. Coinfection of a yaws patient with two closely related Treponema pallidum subsp. pertenue strains: A rare event with potential evolutionary implications.
- Author
-
Medappa, Monica, Pospíšilová, Petra, John, Lucy N., González-Beiras, Camila, Mitjà, Oriol, and Šmajs, David
- Subjects
- *
TREPONEMA pallidum , *MIXED infections , *MOLECULAR cloning , *RECOMBINANT DNA , *SPIROCHETES , *SUBSPECIES - Abstract
• Multiple studies reported inter-strain recombination events in Treponema pallidum. • Treponema pallidum lacks vectors for horizontal DNA transfer. • Here, we elucidate the first step in recombination as a coinfection with two strains. • No compelling evidence of coinfection by two Treponema strains was reported so far. • PCR chimeric clones amplified from the sample resembled recombinant treponemal loci. The etiological agent of yaws is the spirochete Treponema pallidum (TP) subsp. pertenue (TPE) and infects the children of Papua New Guinea, causing ulcerative skin lesions that impairs normal growth and development. Closely related strains of Treponema pallidum subsp. pertenue, J E 11, and T E 13 were detected in an ulcer biospecimen derived from a 5-year-old yaws patient. Cloning experiments validated the presence of two distinct but similar genotypes, namely T E 13 and J E 11, co-occurring within a single host. While coinfection with highly related TPE strains has only limited epidemiological and clinical relevance, this is the first documented coinfection with genetically distinct TP strains in a single patient. Similar coinfections in the past were explained by the existence of over a dozen recombinant loci present in the TP genomes as a result of inter-strain or inter-subspecies recombination events following an anticipated scenario of TP coinfection, i.e., uptake of foreign DNA and DNA recombination. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
176. Coverage, determinants of use and repurposing of long-lasting insecticidal nets two years after a mass distribution in Lihir Islands, Papua New Guinea: a cross-sectional study.
- Author
-
Millat-Martínez, Pere, Gabong, Rebecca, Balanza, Núria, Luana, Sakaia, Sanz, Sergi, Raulo, Silvia, Elizah, Arthur, Wali, Chilaka, Paivu, Benjamin, Dalmas, Julian, Tabie, Samson, Karl, Stephan, Laman, Moses, Pomat, William, Mitjà, Oriol, Baro, Bàrbara, and Bassat, Quique
- Subjects
- *
INSECTICIDE-treated mosquito nets , *MALARIA prevention , *CROSS-sectional method , *FISHING nets , *GENDER , *HOOKAHS - Abstract
Background: Universal coverage with long-lasting insecticidal nets (LLINs) is an essential component of malaria control programmes. Three-yearly mass distribution of LLINs in Papua New Guinea (PNG) has been successful in reducing infection transmission since 2009, but malaria prevalence ramped up from 2015 onwards. Although LLIN universal coverage is mostly achieved during these campaigns, it may not be related with net use over time. Uses given to LLINs and non-compliance of this strategy were evaluated. Methods: A knowledge, attitude and practice (KAP) cross-sectional study was conducted in Lihir Islands, PNG, 2–2.5 years after the last LLIN mass distribution campaign. Data on bed net ownership, use and maintenance behaviour was collected using a household questionnaire administered by trained community volunteers. Logistic regression models were used to identify factors associated with owning at least one LLIN and sleeping under a LLIN the previous night. Results: Among 2694 households surveyed, 27.4 % (95 % CI: 25.8–29.2) owned at least one LLIN and 8.7 % (95 % CI: 7.6–9.8) had an adequate LLIN coverage (at least one LLIN for every two people). Out of 13,595 individuals in the surveyed households, 13.6 % (95 % CI: 13.0-–4.2) reported having slept under a LLIN the preceding night. Determinants for sleeping under LLIN included living in a household with adequate LLIN coverage [adjusted OR (aOR) = 5.82 (95 % CI: 3.23–10.49)], household heads knowledge about LLINs [aOR = 16.44 (95 % CI: 8.29–32.58)], and female gender [aOR = 1.92 (95 % CI: 1.53–2.40)] (all p-values < 0.001). LLIN use decreased with older age [aOR = 0.29 (95 % CI: 0.21–0.40) for ≥ 15 year-olds, aOR = 0.38 (95 % CI: 0.27–0.55) for 5–14 year-olds] compared to < 5 year-olds (p-value < 0.001). Knowledge on the use of LLIN was good in 37.0 % of the household heads. Repurposed nets were reported serving as fishing nets (30.4 %), fruits and seedlings protection (26.6 %), covering up food (19.0 %) and bed linen (11.5 %). Conclusions: Two years after mass distribution, LLIN coverage and use in Lihir Islands is extremely low. Three yearly distribution campaigns may not suffice to maintain an acceptable LLIN coverage unless knowledge on maintenance and use is promoted trough educational campaigns. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
177. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
- Author
-
Marks, Michael, Millat-Martinez, Pere, Ouchi, Dan, Roberts, Chrissy h, Alemany, Andrea, Corbacho-Monné, Marc, Ubals, Maria, Tobias, Aurelio, Tebé, Cristian, Ballana, Ester, Bassat, Quique, Baro, Bàrbara, Vall-Mayans, Martí, G-Beiras, Camila, Prat, Nuria, Ara, Jordi, Clotet, Bonaventura, and Mitjà, Oriol
- Subjects
- *
COUGH , *COVID-19 , *VIRAL load , *COHORT analysis , *SARS-CoV-2 - Abstract
Background: Scarce data are available on what variables affect the risk of transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the development of symptomatic COVID-19, and, particularly, the relationship with viral load. We aimed to analyse data from linked index cases of COVID-19 and their contacts to explore factors associated with transmission of SARS-CoV-2.Methods: In this cohort study, patients were recruited as part of a randomised controlled trial done between March 17 and April 28, 2020, that aimed to assess if hydroxychloroquine reduced transmission of SARS-CoV-2. Patients with COVID-19 and their contacts were identified by use of the electronic registry of the Epidemiological Surveillance Emergency Service of Catalonia (Spain). Patients with COVID-19 included in our analysis were aged 18 years or older, not hospitalised, had quantitative PCR results available at baseline, had mild symptom onset within 5 days before enrolment, and had no reported symptoms of SARS-CoV-2 infections in their accommodation or workplace within the 14 days before enrolment. Contacts included were adults with a recent history of exposure and absence of COVID-19-like symptoms within the 7 days preceding enrolment. Viral load of contacts, measured by quantitative PCR from a nasopharyngeal swab, was assessed at enrolment, at day 14, and whenever the participant reported COVID-19-like symptoms. We assessed risk of transmission and developing symptomatic disease and incubation dynamics using regression analysis. We assessed the relationship of viral load and characteristics of cases (age, sex, number of days from reported symptom onset, and presence or absence of fever, cough, dyspnoea, rhinitis, and anosmia) and associations between risk of transmission and characteristics of the index case and contacts.Findings: We identified 314 patients with COVID-19, with 282 (90%) having at least one contact (753 contacts in total), resulting in 282 clusters. 90 (32%) of 282 clusters had at least one transmission event. The secondary attack rate was 17% (125 of 753 contacts), with a variation from 12% when the index case had a viral load lower than 1 × 106 copies per mL to 24% when the index case had a viral load of 1 × 1010 copies per mL or higher (adjusted odds ratio per log10 increase in viral load 1·3, 95% CI 1·1-1·5). Increased risk of transmission was also associated with household contact (3·0, 1·59-5·65) and age of the contact (per year: 1·02, 1·01-1·04). 449 contacts had a positive PCR result at baseline. 28 (6%) of 449 contacts had symptoms at the first visit. Of 421 contacts who were asymptomatic at the first visit, 181 (43%) developed symptomatic COVID-19, with a variation from approximately 38% in contacts with an initial viral load lower than 1 × 107 copies per mL to greater than 66% for those with an initial viral load of 1 × 1010 copies per mL or higher (hazard ratio per log10 increase in viral load 1·12, 95% CI 1·05-1·20; p=0·0006). Time to onset of symptomatic disease decreased from a median of 7 days (IQR 5-10) for individuals with an initial viral load lower than 1 × 107 copies per mL to 6 days (4-8) for those with an initial viral load between 1 × 107 and 1 × 109 copies per mL, and 5 days (3-8) for those with an initial viral load higher than 1 × 109 copies per mL.Interpretation: In our study, the viral load of index cases was a leading driver of SARS-CoV-2 transmission. The risk of symptomatic COVID-19 was strongly associated with the viral load of contacts at baseline and shortened the incubation time of COVID-19 in a dose-dependent manner.Funding: YoMeCorono, Generalitat de Catalunya.Translations: For the Catalan translation of the abstract see Supplementary Materials section. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
178. Multiple Class I and Class II Haemophilus ducreyi Strains Cause Cutaneous Ulcers in Children on an Endemic Island.
- Author
-
Grant, Jacob C, González-Beiras, Camila, Amick, Kristen M, Fortney, Kate R, Gangaiah, Dharanesh, Humphreys, Tricia L, Mitjà, Oriol, Abecasis, Ana, and Spinola, Stanley M
- Subjects
- *
ULCER diagnosis , *ULCER prevention , *DNA , *DRUG administration , *GENOMES , *HOST-bacteria relationships , *HAEMOPHILUS diseases , *PUBLIC health , *ULCERS , *SEQUENCE analysis , *MIXED infections , *DISEASE complications , *CHILDREN , *PREVENTION , *DIAGNOSIS - Abstract
Background Together with Treponema pallidum subspecies pertenue, Haemophilus ducreyi is a major cause of exudative cutaneous ulcers (CUs) in children. For H. ducreyi, both class I and class II strains, asymptomatic colonization, and environmental reservoirs have been found in endemic regions, but the epidemiology of this infection is unknown. Methods Based on published whole-genome sequences of H. ducreyi CU strains, a single-locus typing system was developed and applied to H. ducreyi– positive CU samples obtained prior to, 1 year after, and 2 years after the initiation of a mass drug administration campaign to eradicate CU on Lihir Island in Papua New Guinea. DNA from the CU samples was amplified with class I and class II dsrA -specific primers and sequenced; the samples were classified into dsrA types, which were geospatially mapped. Selection pressure analysis was performed on the dsrA sequences. Results Thirty-seven samples contained class I sequences, 27 contained class II sequences, and 13 contained both. There were 5 class I and 4 class II types circulating on the island; 3 types accounted for approximately 87% of the strains. The composition and geospatial distribution of the types varied little over time and there was no evidence of selection pressure. Conclusions Multiple strains of H. ducreyi cause CU on an endemic island and coinfections are common. In contrast to recent findings with T. pallidum pertenue, strain composition is not affected by antibiotic pressure, consistent with environmental reservoirs of H. ducreyi. Such reservoirs must be addressed to achieve eradication of H. ducreyi. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
179. Single-Dose Azithromycin for the Treatment of Haemophilus ducreyi Skin Ulcers in Papua New Guinea.
- Author
-
González-Beiras, Camila, Kapa, August, Vall-Mayans, Marti, Paru, Raymond, Gavilán, Sergi, Houinei, Wendy, Bieb, Sibauk, Sanz, Sergi, Martins, Rosario, and Mitjà, Oriol
- Subjects
- *
CONFIDENCE intervals , *HAEMOPHILUS diseases , *LONGITUDINAL method , *POLYMERASE chain reaction , *AZITHROMYCIN , *TREATMENT effectiveness , *RETROSPECTIVE studies , *SKIN ulcers - Abstract
Background. Haemophilus ducreyi (HD) and Treponema pallidum subspecies pertenue (TP) are major causative agents of cutaneous ulcer (CU) in the tropics. Azithromycin is recommended to treat sexually transmitted HD infections and has good in vitro activity against HD strains from both genital and skin ulcers. We investigated the efficacy of oral single-dose azithromycin on HD-CU. Methods. We conducted a community-based cohort study in Lihir Island, Papua New Guinea, from October 2014 through May 2016. Consenting patients with skin ulcers >1 cm in diameter were eligible for this study and had collected a lesional swab for polymerase chain reaction (PCR). All participants were treated with single-dose azithromycin (30 mg/kg) and were followed up for assessment of clinical resolution. We retrospectively classified patients according to PCR results into HD, TP, and PCR-negative groups. The primary endpoint was healing rates of HD-CU at 14 days after treatment. Results. We obtained full outcome data from 246 patients; 131 (53.3%) were HD PCR positive, 37 (15.0%) were TP positive, and 78 (31.7%) were negative for all tests. Healing rates were 88.5% (95% confidence interval [CI], .82-.93) in the HD group, 78.4% [95% CI, .63-.89] in the TP group, and 74.4% (95% CI, .64-.83) in the PCR-negative group. If we included the participants with improved ulcers, the healing rates increased to 94.7%, 97.3%, and 89.7% respectively. HD cases classified as not healed all converted to HD-negative PCR. Conclusions. Based upon clinical resolution and PCR conversion to HD negative, a single oral dose of azithromycin is efficacious for the treatment of HD-CU. These results have implications for the treatment of individual patients and for the use of antibiotics in public health strategies to control CU in the tropics. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
180. Metaanalysis of the Performance of a Combined Treponemal and Nontreponemal Rapid Diagnostic Test for Syphilis and Yaws.
- Author
-
Marks, Michael, Yin, Yue-Ping, Chen, Xiang-Sheng, Castro, Arnold, Causer, Louise, Guy, Rebecca, Wangnapi, Regina, Mitjà, Oriol, Aziz, Abdul, Castro, Rita, Pereira, Filomena da Luz Martins, Taleo, Fasihah, Guinard, Jérôme, Bélec, Laurent, Tun, Ye, Bottomley, Christian, Ballard, Ronald C., and Mabey, David C. W.
- Subjects
- *
TREPONEMATOSES , *YAWS , *DIAGNOSIS , *DIAGNOSIS of syphilis , *MEDICAL screening - Abstract
Background. The human treponematoses are important causes of disease. Mother-to-child transmission of syphilis remains a major cause of stillbirth and neonatal death. There are also almost 100 000 cases of endemic treponemal disease reported annually, predominantly yaws. Rapid diagnostic tests (RDTs) would improve access to screening for these diseases. Most RDTs cannot distinguish current and previous infection. The Dual Path Platform (DPP) Syphilis Screen & Confirm test includes both a treponemal (T1) and nontreponemal (T2) component and may improve the accuracy of diagnosis. Methods. We conducted a metaanalysis of published and unpublished evaluations of the DPP-RDT for the diagnosis of syphilis and yaws. We calculated the sensitivity, specificity, and overall agreement of the test compared with reference laboratory tests. Results. Nine evaluations, including 7267 tests, were included. Sensitivity was higher in patients with higher titer rapid plasma reagin (≥1:16) for both the T1 (98.2% vs 90.1%, P< .0001) and the T2 component (98.2% vs 80.6%, P< .0001). Overall agreement between the DPP test and reference serology was 85.2% (84.4%-86.1%). Agreement was highest for high-titer active infection and lowest for past infection. Conclusions. The RDT has good sensitivity and specificity of the treponemal and nontreponemal components both in cases of suspected syphilis and yaws, although the sensitivity is decreased at lower antibody titers. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
181. Refining the guidelines for the treatment and management of Cutaneous Ulcers through research in endemic population Papua New Guinea
- Author
-
BEIRAS, Camila González, MARTINS, Maria do Rosário Oliveira, MITJÀ, Oriol, and ABECASIS, Ana
- Subjects
Úlcera cutânea ,Saúde pública ,Haemophilus ducreyi, Bouba ,Ciências Médicas [Domínio/Área Científica] ,Treponema Pallidum ,Papua Nova guiné - Abstract
As úlceras cutâneas (UC), lesões cutâneas com perda das camadas superficiais da pele, são comumente encontradas em países de baixo rendimento da África e do Pacífico Sul. Em certas áreas remotas e rurais, como as ilhas da Papua Nova Guiné, a prevalência e a morbidade de UC são muito altas, representando, portanto, uma importante causa de sofrimento e estigmatização em crianças. Certas UC, se não forem tratadas, podem resultar em deformidades permanentes que afetam a vida das pessoas e que estão associadas a pobreza. Embora vários agentes patogénicos possam causar UC, dois deles representam um grande problema de saúde pública nas ilhas do Pacífico Sul - bouba (Treponema pallidum pertenue) e Haemophilus ducreyi. Estes dois agentes patogénicos são a base desta tese e foram selecionados por variadas razões: em primeiro lugar, são as duas causas mais comuns de UC na região tropical do Pacífico Sul, onde os estudos para esta tese foram realizados. Em segundo lugar, estes são co endémicos, mas a sua interação como doenças infeciosas não foi estudada. Em terceiro lugar, por motivos epidemiológicos, clínicos e terapêuticos, as duas doenças são potencialmente tratáveis de forma integrada por meio do tratamento total da comunidade (TTC) com administração em massa de antibióticos (AMM) . A bouba é classificada pela Organização Mundial da Saúde (OMS) como uma doença tropical negligenciada (DTN) que afeta principalmente crianças de 6 a 15 anos de idade em comunidades com falta de água e sem saneamento, levando à desfiguração e incapacidade crónica. No passado, a bouba foi sempre considerada a causa mais comum de UC, mas estudos de coorte recentes conduzidos na Papua Nova Guiné (PNG), Ilhas Salomão e Vanuatu identificaram o H. ducreyi como o agente etiológico que causa mais de metade de todas as UCs nos trópicos. Em cenários endémicos de bouba rural, onde há ausência de diagnósticos moleculares, as UCs são classificadas com base nos resultados dos testes sorológicos da sífilis. Por exemplo, uma UC com um teste serológico positivo é classificada como bouba e tratada com azitromicina oral de dose única, enquanto uma UC com um resultado serológico negativo é classificada como úlceras não-bouba (por exemplo, H. ducreyi ou outros agentes patogénicos) e tratada com curso de 5-7 dias de diferentes antibióticos de amplo espectro. Esquemas de dosagem de múltiplos dias de tratamento e várias vezes por dia comprometem a adesão e satisfação do paciente.Recentemente, um alarmante ressurgimento de bouba foi observado em vários países nos trópicos. O maior número de casos é relatado na Papua Nova Guiné, Ilhas Salomão e Gana. A OMS reagiu ao ressurgimento de bouba conduzindo campanhas de eliminação em áreas altamente endémicas usando tratamento empírico de UC com azitromicina oral de dose única. No entanto, se somente a bouba for tratada durante as campanhas, as comunidades podem ter a perceção de que a persistência de outros tipos de UC estará relacionada com um desfecho negativo da estratégia. A recente descoberta de que H. ducreyi é um dos principais agentes causadores de UC reforça a necessidade de maior investigação sobre o assunto. É preciso explorar novas estratégias para controlar a UC por H. ducreyi juntamente com a bouba. Em 2012, um ensaio clínico realizado na Papua Nova Guiné mostrou que a azitromicina era eficaz para tratar a bouba ativa. No entanto, para nosso conhecimento, há dados limitados sobre a eficácia do AMM com azitromicina para curar a infeção latente da bouba ou para eliminar a UC H. ducreyi como um efeito secundário benéfico. A azitromicina tem a vantagem de ser administrada em dose oral única e a um preço muito acessível em comparação com outros regimes de antibióticos. Se comprovadamente eficaz para o tratamento de UC por H. ducreyi e para a bouba latente, teria implicações para o tratamento de pacientes individuais e para o uso de antibióticos em estratégias de saúde pública para controlar a UC nos trópicos. Além disso, compreender a transmissão da UC de H. ducreyi permitirá definir novas estratégias para controlar e deter a propagação da doença. Os artigos originais desta tese pretendem fornecer uma atualização sobre a epidemiologia mundial da UC e bouba de H. ducreyi, investigar a eficácia da azitromicina de dose única no tratamento de pacientes com UC por H. ducreyi e bouba latente, explorar a transmissão e reservatórios ambientais de H. ducreyi e apresentar dados de eficácia a longo prazo da estratégia de AMM para eliminar a bouba e reduzir a prevalência de H. ducreyi a nível comunitário. Cutaneous Ulcers (CU) presenting as skin lesions with loss of the superficial skin layers are commonly found in low-resource countries of Africa and the South Pacific. In certain remote and rural areas, such as the islands of Papua New Guinea, CU prevalence and morbidity is very high, hence representing an important cause of suffering and stigmatization in children. Certain CU conditions, if untreated, can result into permanent impairing deformities that will impact the person’s life and anchor that person into poverty. Although several pathogens may cause CU, two of them pose a major public health problem in the South Pacific islands, namely yaws (Treponema pallidum pertenue) and Haemophilus ducreyi and are the basis of this thesis. These two pathogens were selected for a number of reasons: first they are the two most common causes of CU in the tropical South Pacific region where the studies for this thesis were conducted. Second, these are co-endemic but its interaction as infectious diseases has not been studied. And third, because of epidemiological, clinical and therapeutic reasons the two diseases are potentially treatable in an integrated manner through total community treatment (TCT) with mass drug administration (MDA) of antibiotics. Yaws is classified by the World Health Organization (WHO) as a neglected tropical disease (NTD) that primarily affects children 6-15 years old in communities with poor water supplies and no sanitation, and leads to chronic disfigurement and disability. In the past yaws was always considered the most common cause of CU, yet recent cohort studies conducted in Papua New Guinea (PNG), Solomon Islands and Vanuatu have identified Haemophilus ducreyi as an aetiologic agent causing more than half of all CU in the tropics. In rural yaws endemic settings where there is absence of molecular diagnostics, CUs are classified on the basis of syphilis serological test results. For example, a CU with a positive serological test is classified as yaws and treated with single dose oral azithromycin, while a CU with a negative serological result is classified as non-yaws ulcers (e.g. H. ducreyi or other pathogens) and treated with a 5-7 day course of different wide-spectrum antibiotics.Multiple days courses of treatment and multiple times per day dosing schedules compromise patient compliance and satisfaction. Recently, an alarming resurgence of yaws has been observed in several countries in the tropics. The largest number of cases are reported in Papua New Guinea, Solomon Islands, and Ghana. WHO has responded to yaws resurgence by conducting Elimination Campaigns in highly endemic areas using empirical treatment of CU with single-dose oral azithromycin. If only yaws is treated during campaigns, communities might have the perception that persistence of other types of CU is related to a poor outcome of the strategy. The recent discovery that H. ducreyi was as a major causative agent of CU calls for further research on this matter. New strategies to control H. ducreyi CU together with yaws need to be explored. In 2012, a clinical trial conducted in Papua New Guinea showed that azithromycin was efficacious to treat active yaws. However, to our knowledge there is limited data on the efficacy of azithromycin MDA to cure latent yaws infection, or to eliminate H. ducreyi CU as a beneficial secondary effect. Azithromycin offers the advantage of single oral dose at a very cheap price as compared to other antibiotic regimens; if proven efficacious for H. ducreyi CU and latent yaws, this would have implications for the treatment of individual patients and for the use of antibiotics in public health strategies to control CU in the tropics. Furthermore, understanding the transmission of H. ducreyi CU will helps us define new strategies to control and stop the spread of the disease. This thesis original research articles aim to provide an update on the worldwide epidemiology of H. ducreyi CU and yaws, to investigate the efficacy of single-dose azithromycin to treat individual patients with H. ducreyi CU and latent yaws, to explore the transmission and environmental reservoirs of H. ducreyi, and to present long-term efficacy data of the MDA strategy to eliminate yaws and reduce the prevalence of H. ducreyi at a community level.
- Published
- 2018
182. Mass Treatment with Single-Dose Azithromycin for Yaws.
- Author
-
Eckhoff, Grace, Eckhoff, Philip, Wood, Lowell, Mitjà, Oriol, Lukehart, Sheila, and Bassat, Quique
- Subjects
- *
ANTIBIOTICS , *AZITHROMYCIN , *YAWS , *THERAPEUTICS - Abstract
A letter to the editor is presented in response to the article "Mass treatment with single-dose azithromycin for yaws" by O. Mitjà in the February 19, 2015 issue.
- Published
- 2016
- Full Text
- View/download PDF
183. High increase of Nichols-like clade circulating Treponema pallidum subsp. pallidum in Barcelona from 2021 to 2023.
- Author
-
Nadal-Barón P, Trejo-Zahinos J, Arando M, Barberan-Masegosa A, Bernat-Sole M, Pérez-Ugarte A, Villatoro AM, Alcubilla P, Sulleiro E, Gonzalez-López JJ, Antón A, Alberny M, Mitjà O, Larrosa MN, and Hoyos-Mallecot Y
- Subjects
- Spain, Humans, Multilocus Sequence Typing, Male, Macrolides pharmacology, Phylogeny, Mutation, Female, RNA, Ribosomal, 16S genetics, Adult, Anti-Bacterial Agents pharmacology, Drug Resistance, Bacterial genetics, Middle Aged, Haplotypes, DNA, Bacterial genetics, Treponema pallidum genetics, Treponema pallidum drug effects, Treponema pallidum classification, Treponema pallidum isolation & purification, Syphilis microbiology, Syphilis epidemiology
- Abstract
Worldwide, more than 90% of contemporary syphilis strains belong to SS14-like clade. This study aimed to describe the molecular profile of circulating Treponema pallidum subsp. pallidum (TPA) strains in Barcelona, Spain, from 2021 to 2023 building upon our report in 2015 which showed that 94.8% of typed strains belonged to the SS14 clade. Multilocus sequence typing (MLST) was conducted on TPA-positive samples obtained from swab samples by sequencing the tp0136, tp0548, and tp0705 loci. Strains were classified as Nichols-like or SS14-like clade. Macrolide and tetracycline resistance‑associated mutations were determined through analysis of 23S rDNA and 16S rRNA gene sequences. Of the 96 typeable samples, 47.9% belonged to SS14-like and 52.1% to the Nichols-like. Fourteen haplotypes were identified, with ST26 representing 43.8% of the samples, distributed across 11 haplotypes in the SS14-like and 3 haplotypes in the Nichols-like. All the samples showed macrolide resistance-associated mutations, while none exhibited tetracycline-associated mutations. Our findings revealed a substantial shift in the proportion of TPA clades within the Barcelona population from 2021 to 2023, characterized by a higher proportion of Nichols-like strains compared to 2015 and international trends. The varying temporal and geographical trends underscore the need for regular surveillance to understand regional variations in syphilis and strengthen control programs., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
184. An integrated active case detection and management of skin NTDs in yaws endemic health districts in Cameroon, Côte d'Ivoire and Ghana.
- Author
-
Tchatchouang S, Basing LA, Kouadio-Aboh H, Handley BL, G-Beiras C, Amanor I, Ndzomo P, Bakheit M, Becherer L, Knauf S, Müller C, Njih-Tabah E, Njamnshi T, Crucitti T, Borst N, Lüert S, Frischmann S, Gmoser H, Landmann E, Sylla A, Kouamé-Sina MS, Arhinful D, Awondo P, Menguena G, Harding-Esch EM, Tano A, Kaloga M, Koffi-Aboa P, Konama-Kotey N, Mitjà O, Eyangoh S, Kwasi-Addo K, Ngazoa-Kakou S, and Marks M
- Abstract
Background: Integrated approaches to mapping skin Neglected Tropical Diseases (NTDs) may be cost-effective way to guide decisions on resource mobilization. Pilot studies have been carried out, but large-scale data covering multiple countries endemic for skin NTDs are lacking. Within the LAMP4YAWS project, we collected integrated data on the burden of multiple skin NTDs., Methods: From March 2021 to March 2023, integrated case searches for yaws alongside other skin conditions were performed in endemic health districts of yaws in Cameroon, Côte d'Ivoire, and Ghana. Integrated activities included training, social mobilization and active case detection. Initial screening involved a brief clinical examination of participants to determine if any skin conditions were suspected. Cases of skin NTDs were then referred to a health facility for appropriate management., Results: Overall 61,080 individuals screened, 11,387 (18.6%) had skin lesions. The majority of individuals (>90%) examined were children aged 15 years old and under. The proportion of serologically confirmed yaws cases was 8.6% (18/210) in Cameroon, 6.8% (84/1232) in Côte d'Ivoire, and 26.8% (440/1643) in Ghana. Other skin conditions based on clinical examination included: scabies, Buruli ulcer, leprosy, lymphatic filariasis (lymphoedema and hydrocele), tungiasis, and fungal infections. The most common conditions were scabies and superficial fungal infections. In Cameroon, scabies and superficial fungal infections accounted for 5.1% (214/4204) and 88.7% (3730/4204) respectively, 25.2% (1285/5095) and 50.4% (2567/5095) in Côte d'Ivoire. In Ghana, 20% (419/2090) of individuals had scabies but superficial fungal infections were not routinely recorded and were reported in only 1.3% (28/2090). Other skin NTDs were less common across all three countries., Conclusion: This study confirms that integrated screening allows simultaneous detection of multiple skin NTDs, maximising use of scarce resources., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Tchatchouang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
185. Sequence typing of Haemophilus ducreyi isolated from patients in the Namatanai region of Papua New Guinea: Infections by Class I and Class II strain types differ in ulcer duration and resurgence of infection after azithromycin treatment.
- Author
-
Medappa M, Pospíšilová P, John LN, González-Beiras C, Vall-Mayans M, Mitjà O, and Šmajs D
- Subjects
- Humans, Papua New Guinea epidemiology, Female, Male, Child, Adolescent, Adult, Child, Preschool, Young Adult, RNA, Ribosomal, 16S genetics, Yaws microbiology, Yaws epidemiology, Yaws drug therapy, Middle Aged, Sequence Analysis, DNA, DNA, Bacterial genetics, Pilot Projects, Phylogeny, Haemophilus ducreyi genetics, Haemophilus ducreyi isolation & purification, Haemophilus ducreyi drug effects, Azithromycin therapeutic use, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents pharmacology, Chancroid microbiology, Chancroid epidemiology, Chancroid drug therapy, Genotype
- Abstract
Haemophilus ducreyi (HD) is an important cause of cutaneous ulcers in several endemic regions, including the Western Pacific Region, especially among children. An HD sequence typing on swab samples taken from 1,081 ulcers in the Namatanai district of Papua New Guinea, during the pilot study for treatment of yaws, has been performed using the Grant typing system. Of the 363 samples that tested positive for the 16S rDNA of HD, the dsrA sequences of 270 samples were determined. Altogether they revealed 8 HD strain types circulating in Namatanai, including seven strain types of Class I (I.3, I.4, I.5, I.9, I.10, I.11, I.12) and one strain of Class II (II.3); four Class I types (I.9, I.10, I.11, I.12) were novel. The southern region of Namatanai (Matalai Rural) was identified as the region with the lowest genotype diversity and with most infections caused by HD Class II. The middle and northern subdistricts were affected mainly by HD Class I. Analysis of patient characteristics revealed that Class II HD infections were more often represented by longer-lasting ulcers than Class I HD infections. An increase in the prevalence of the I.10 strain was found after azithromycin administration compared to the untreated population at baseline likely reflecting higher infectivity of HD Class I, and more specifically strain type I.10., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Medappa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
186. Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study.
- Author
-
Moraes-Cardoso I, Benet S, Carabelli J, Perez-Zsolt D, Mendoza A, Rivero A, Alemany A, Descalzo V, Alarcón-Soto Y, Grifoni A, Sette A, Moltó J, Marc A, Marks M, Mitjà O, Brander C, Paredes R, Izquierdo-Useros N, Carrillo J, Suñer C, Olvera A, and Mothe B
- Subjects
- Humans, Male, Spain epidemiology, Prospective Studies, Adult, Female, Middle Aged, Antibodies, Viral blood, Antibodies, Viral immunology, Immunoglobulin G blood, Immunoglobulin G immunology, Immunoglobulin A blood, Immunoglobulin A immunology, Viral Load, T-Lymphocytes immunology, HIV Infections immunology, HIV Infections epidemiology
- Abstract
Background: Since the emergence of the global mpox outbreak in May, 2022, more than 90 000 cases have been diagnosed across 110 countries, disproportionately affecting people with HIV. The durability of mpox-specific immunity is unclear and reinfections have been reported. We aimed to compare mpox immune responses up to 6 months after diagnosis in participants with and without HIV and assess their effect on disease severity and viral clearance dynamics., Methods: This study was embedded within a prospective, observational, multicentre cohort study of viral clearance dynamics among people with mpox in Spain (MoViE). We included women and men aged 18 years or older, who had signs of mpox, and reported having symptom onset within the previous 10 days at the moment of mpox diagnosis from three sex clinics of the Barcelona metropolitan area. Samples from skin ulcers were collected weekly to estimate the time to clear monkeypox virus (MPXV) from skin lesions. Blood samples were taken at diagnosis, 29, 91, and 182 days later for immune analysis. This included quantifying IgG and IgA against three mpox antigens by ELISA, evaluating in-vitro neutralisation, and characterising mpox-specific T-cell responses using interferon γ detecting enzyme-linked immunospot (ELISpot) assay and multiparametric flow cytometry., Findings: Of the 77 originally enrolled participants, we included 33 participants recruited between July 19, and Oct 6, 2022. Participants without HIV (19 [58%] participants) and participants with HIV (14 [42%] participants) had similar clinical severity and time to MPXV clearance in skin lesions. Participants with HIV had a CD4
+ T-cell count median of 777 cells per μL (IQR 484-1533), and 11 (78%) of 14 were virally suppressed on antiretroviral therapy. Nine (27%) of 33 participants were age 49 years or older. 15 (45%) of 33 participants were originally from Spain, and all participants were men. Early humoral responses, particularly concentrations and breadth of IgG and IgA, were associated with milder disease and faster viral clearance. Orthopoxvirus-specific T cells count was also positively correlated with MPXV clearance. Antibody titres declined more rapidly in participants with HIV, but T-cell responses against MPXV were sustained up to day 182 after diagnosis, regardless of HIV status., Interpretation: Higher breadth and magnitude of B-cell and T-cell responses are important in facilitating local viral clearance, limiting mpox dissemination, and reducing disease severity in individuals with preserved immune system. Antibodies appear to contribute to early viral control and T-cell responses are sustained over time, which might contribute to milder presentations during reinfection., Funding: Fundació Lluita contra les Infeccions, IrsiCaixa, and Consorcio Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación e Universidades., Competing Interests: Declaration of interests BM reports consultancy personal fees from AELIX Therapeutics and AbbViE and speaker fees from Gilead, Janssen, and ViiV Healthcare. AG is a consultant for Pfizer, outside the submitted work. CB is cofounder, CSO, and shareholder of AELIX Therapeutics and reports consultancy personal fees from Omniscope, Virometix, and Astrivax. AS is a consultant for AstraZeneca Pharmaceuticals, Calyptus Pharmaceuticals, Darwin Health, EmerVax, EUROIMMUN, F Hoffman-La Roche, Fortress Biotech, Gilead Sciences, Gritstone Oncology, Guggenheim Securities, Moderna, Pfizer, RiverVest Venture Partners, and Turnstone Biologics. NI-U reports funding support from the Spanish Ministry of Science and Innovation, HIPRA, Pharma Mar, Amassence, Mynorix, Grifols, and SME. RP reports financial fundings from MSD, ViiV Healthcare, Gilead Sciences, and PharmaMar, and consulting fees or honoraria from Gilead Sciences, Pfizer, AstraZeneca, Roche therapeutics, MSD, GSK ViiV Healthcare, Eli Lilly and Company, PharmaMar, and Atea Pharmaceutics. JM reports consulting fees, honoraria, expert testimony payment, and financial support from ViiV Healthcare, Johnson & Jonhson, Gilead, and MSD. La Jolla Institute has filed for patent protection for various aspects of T-cell epitope and vaccine design work. The authors declare no other competing interests., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
187. Knowledge, attitudes and practices towards yaws in endemic areas of Ghana, Cameroon and Côte d'Ivoire.
- Author
-
Beiras CG, Kouadio AT, Handley BL, Arhinful D, Tchatchouang S, Houndji ASS, Nartey ET, Sarpong DO, Menguena G, Ndzomo P, Basing LA, Hugues KA, Amanor IB, Bakheit M, Landmann E, Awondo P, Müller C, Crucitti T, Borst N, Becherer L, Lüert S, Frischmann S, Sylla A, Kouamé-Sina MS, Harding-Esch EM, Knauf S, Mitjà O, Eyangoh S, Addo KK, Kakou SN, and Marks M
- Subjects
- Humans, Cameroon epidemiology, Cote d'Ivoire epidemiology, Ghana epidemiology, Female, Male, Adult, Middle Aged, Young Adult, Adolescent, Community Health Workers psychology, Aged, Treponema pallidum, Yaws epidemiology, Health Knowledge, Attitudes, Practice
- Abstract
Yaws, caused by Treponema pallidum ssp. pertenue, remains a significant public health concern in tropical regions of West Africa and the South Pacific, primarily affecting children in remote areas with limited access to hygiene and sanitation. In this study, conducted in three endemic countries of West Africa where yaws remains a significant public health concern (Ghana, Cameroon, and Côte d'Ivoire), we aimed to assess the knowledge, attitudes, and practices related to yaws among community members, community health workers (CHWs), and traditional healers. The study revealed variations in the perception of causes of yaws among community members: the majority or participants in Ghana attributed yaws to germs (60.2%); in Cameroon the most reported form of transmission was contact with or drinking infected water sources (44.6%); and in Côte d'Ivoire both of these answers were also the most prevalent (60.3% germs and 93.% water sources). A substantial proportion of participants in Côte d'Ivoire also associated yaws with witchcraft and divine punishment (44.8%). Only a small proportion of individuals in Ghana and Côte d'Ivoire correctly identified contact with an infected person as a form of transmission (11.9% and 20.7%, respectively) and less than half in Cameroon (42.6%), although more than 98% of all participants reported avoidance behaviours towards yaws infected people due to fear of getting infected. Most participants expressed a preference for seeking care at hospitals (49.2%, 60.6%, 86.2%) or health care professionals including doctors and nurses (58.5%, 41,5% and 17.2%) if they were diagnosed with yaws, although a quarter of participants in Côte d'Ivoire also sought support from traditional healers. The CHWs interviewed were generally well-trained on yaws causes and treatment options, although they often reported low availability of treatment and diagnostic tests for yaws. Our findings underscore the need for community education, awareness campaigns, ongoing CHW training, and improved access to yaws treatment and diagnostic resources. The data also suggest that collaboration with traditional healers, who usually hold a highly esteemed position in the society, such as giving training on yaws causes and transmission or exchanging knowledge on treatment options, could be beneficial in certain regions, particularly in Côte d'Ivoire., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Beiras et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
188. Author Correction: Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients.
- Author
-
Millat-Martinez P, Gharbharan A, Alemany A, Rokx C, Geurtsvankessel C, Papageorgiou G, van Geloven N, Jordans C, Groeneveld G, Swaneveld F, van der Schoot E, Corbacho-Monné M, Ouchi D, Piccolo Ferreira F, Malchair P, Videla S, García García V, Ruiz-Comellas A, Ramírez-Morros A, Rodriguez Codina J, Amado Simon R, Grifols JR, Blanco J, Blanco I, Ara J, Bassat Q, Clotet B, Baro B, Troxel A, Zwaginga JJ, Mitjà O, and Rijnders BJA
- Published
- 2024
- Full Text
- View/download PDF
189. Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial.
- Author
-
Ubals M, Nadal-Baron P, Arando M, Rivero Á, Mendoza A, Descalzo Jorro V, Ouchi D, Pérez-Mañá C, Álvarez M, Alemany A, Hoyos-Mallecot Y, Nunley E, Lieberman NAP, Greninger AL, Galván-Casas C, Suñer C, G-Beiras C, Paredes R, Rodríguez-Gascón A, Canut A, García-Patos V, Farré M, Marks M, Giacani L, Vall-Mayans M, and Mitjà O
- Subjects
- Adult, Humans, Anti-Bacterial Agents, Drug Resistance, Bacterial, Linezolid therapeutic use, Macrolides pharmacology, Prospective Studies, Reagins, Recurrence, Spain, Treatment Outcome, Penicillin G Benzathine therapeutic use, Syphilis drug therapy
- Abstract
Background: Management of syphilis, a sexually transmitted infection (STI) with increasing incidence, is challenged by drug shortages, scarcity of randomised trial data, an absence of non-penicillin alternatives for pregnant women with penicillin allergy (other than desensitisation), extended parenteral administration for neurosyphilis and congenital syphilis, and macrolide resistance. Linezolid was shown to be active against Treponema pallidum, the causative agent of syphilis, in vitro and in the rabbit model. We aimed to assess the efficacy of linezolid for treating early syphilis in adults compared with the standard of care benzathine penicillin G (BPG)., Methods: We did a multicentre, open-label, non-inferiority, randomised controlled trial to assess the efficacy of linezolid for treating early syphilis compared with BPG. We recruited participants with serological or molecular confirmation of syphilis (either primary, secondary, or early latent) at one STI unit in a public hospital and two STI community clinics in Catalonia (Spain). Participants were randomly allocated in a 1:1 ratio using a computer-generated block randomisation list with six participants per block, to receive either oral linezolid (600 mg once per day for 5 days) or intramuscular BPG (single dose of 2·4 million international units) and were assessed for signs and symptoms (once per week until week 6 and at week 12, week 24, and week 48) and reagin titres of non-treponemal antibodies (week 12, week 24, and week 48). The primary endpoint was treatment response, assessed using a composite endpoint that included clinical response, serological response, and absence of relapse. Clinical response was assessed at 2 weeks for primary syphilis and at 6 weeks for secondary syphilis following treatment initiation. Serological cure was defined as a four-fold decline in rapid plasma reagin titre or seroreversion at any of the 12-week, 24-week, or 48-week timepoints. The absence of relapse was defined as the presence of different molecular sequence types of T pallidum in recurrent syphilis. Non-inferiority was shown if the lower limit of the two-sided 95% CI for the difference in rates of treatment response was higher than -10%. The primary analysis was done in the per-protocol population. The trial is registered at ClinicalTrials.gov (NCT05069974) and was stopped for futility after interim analysis., Findings: Between Oct 20, 2021, and Sept 15, 2022, 62 patients were assessed for eligibility, and 59 were randomly assigned to linezolid (n=29) or BPG (n=30). In the per-protocol population, after 48 weeks' follow-up, 19 (70%) of 27 participants (95% CI 49·8 to 86·2) in the linezolid group had responded to treatment and 28 (100%) of 28 participants (87·7 to 100·0) in the BPG group (treatment difference -29·6, 95% CI -50·5 to -8·8), which did not meet the non-inferiority criterion. The number of drug-related adverse events (all mild or moderate) was similar in both treatment groups (five [17%] of 29, 95% CI 5·8 to 35·8 in the linezolid group vs five [17%] of 30, 5·6 to 34·7, in the BPG group). No serious adverse events were reported during follow-up., Interpretation: The efficacy of linezolid at a daily dose of 600 mg for 5 days did not meet the non-inferiority criteria compared with BPG and, as a result, this treatment regimen should not be used to treat patients with early syphilis., Funding: European Research Council and Fondo de Investigaciones Sanitarias., Competing Interests: Declaration of interests RP received grants or contracts from MSD and ViiV Healthcare (payments to his institution) and consulting fees from Pfizer, Gilead, GSK, AstraZeneca, Atea, and Roche. AC has received payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing, or educational events from Pfizer, Merck, Biomerieux, Becton, and Seegene, and has received support for attending meetings or travel from Beckman. YH-M has grants or contracts with Seegene (payments to his institution). All other authors declare no competing interests., (Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
190. Low genetic diversity of Treponema pallidum ssp. pertenue (TPE) isolated from patients' ulcers in Namatanai District of Papua New Guinea: Local human population is infected by three TPE genotypes.
- Author
-
Medappa M, Pospíšilová P, Madruga MPM, John LN, Beiras CG, Grillová L, Oppelt J, Banerjee A, Vall-Mayans M, Mitjà O, and Šmajs D
- Subjects
- Child, Humans, Ulcer, Multilocus Sequence Typing, Papua New Guinea epidemiology, Treponema genetics, Mutation, Genotype, Treponema pallidum genetics, Yaws epidemiology
- Abstract
Yaws is an endemic disease caused by Treponema pallidum subsp. pertenue (TPE) that primarily affects children in rural regions of the tropics. The endemic character of yaws infections and the expected exclusive reservoir of TPE in humans opened a new opportunity to start a yaws eradication campaign. We have developed a multi-locus sequence typing (MLST) scheme for TPE isolates combining the previously published (TP0548, TP0488) and new (TP0858) chromosomal loci, and we compared this typing scheme to the two previously published MLST schemes. We applied this scheme to TPE-containing clinical isolates obtained during a mass drug administration study performed in the Namatanai District of Papua New Guinea between June 2018 and December 2019. Of 1081 samples collected, 302 (28.5%) tested positive for TPE DNA, from which 255 (84.4%) were fully typed. The TPE PCR-positivity in swab samples was higher in younger patients, patients with single ulcers, first ulcer episodes, and with ulcer duration less than six months. Non-treponemal serological test positivity correlated better with PCR positivity compared to treponema-specific serological tests. The MLST revealed a low level of genetic diversity among infecting TPE isolates, represented by just three distinct genotypes (JE11, SE22, and TE13). Two previously used typing schemes revealed similar typing resolutions. Two new alleles (one in TP0858 and one in TP0136) were shown to arise by intragenomic recombination/deletion events. Compared to samples genotyped as JE11, the minor genotypes (TE13 and SE22) were more frequently detected in samples from patients with two or more ulcers and patients with higher values of specific TP serological tests. Moreover, the A2058G mutation in the 23S rRNA genes of three JE11 isolates was found, resulting in azithromycin resistance., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Medappa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
191. Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection.
- Author
-
Nguyen BT, Marc A, Suñer C, Marks M, Ubals M, Hernández-Rodríguez Á, Melendez MÁ, Hruby DE, Russo AT, Mentré F, Mitjà O, Grosenbach DW, and Guedj J
- Subjects
- Animals, Humans, Benzamides, Isoindoles adverse effects, Antiviral Agents pharmacology, Antiviral Agents therapeutic use, Mpox (monkeypox)
- Abstract
Despite use of tecovirimat since the beginning of the 2022 outbreak, few data have been published on its antiviral effect in humans. We here predict tecovirimat efficacy using a unique set of data in nonhuman primates (NHPs) and humans. We analyzed tecovirimat antiviral activity on viral kinetics in NHP to characterize its concentration-effect relationship in vivo. Next, we used a pharmacological model developed in healthy volunteers to project its antiviral efficacy in humans. Finally, a viral dynamic model was applied to characterize mpox kinetics in skin lesions from 54 untreated patients, and we used this modeling framework to predict the impact of tecovirimat on viral clearance in skin lesions. At human-recommended doses, tecovirimat could inhibit viral replication from infected cells by more than 90% after 3 to 5 days of drug administration and achieved over 97% efficacy at drug steady state. With an estimated mpox within-host basic reproduction number, R0, equal to 5.6, tecovirimat could therefore shorten the time to viral clearance if given before viral peak. We predicted that initiating treatment at symptom onset, which on average occurred 2 days before viral peak, could reduce the time to viral clearance by about 6 days. Immediate postexposure prophylaxis could not only reduce time to clearance but also lower peak viral load by more than 1.0 log10 copies/mL and shorten the duration of positive viral culture by about 7 to 10 days. These findings support the early administration of tecovirimat against mpox infection, ideally starting from the infection day as a postexposure prophylaxis., Competing Interests: DWG, DEH, and ATR work for SIGA Technologies Inc. Other authors declare no conflicts of interests., (Copyright: © 2023 Nguyen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
192. Egocentric sexual network analysis among gay and bisexual men who have sex with men with and without mpox infection.
- Author
-
Sönmez İ, Martínez Riveros H, Folch C, Suñer C, Díaz Y, Alonso L, Agusti C, Mendoza A, Tarín-Vicente EJ, Oller X, Alemany A, Rivero À, Orviz E, Silva-Klug A, Mitjà O, and Casabona J
- Subjects
- Male, Humans, Homosexuality, Male, Case-Control Studies, Sexual and Gender Minorities, Mpox (monkeypox), HIV Infections prevention & control, HIV Seropositivity
- Abstract
Objectives: Recent outbreaks of the mpox (monkeypox) virus have been detected in dense sexual networks of gay and bisexual men who have sex with men (GBMSM). The objective of this study is to describe and compare the epidemiological and behavioural characteristics, as well as the sexual networks, of GBMSM diagnosed with mild mpox in Spain., Methods: A prospective case-control study was conducted in Spain from July 2022 to February 2023. The study targeted a key population of GBMSM aged 18 years or older. Study participants were categorised into cases, those who were diagnosed with mpox virus infection; and controls, those who were not diagnosed. We examined and compared the sexual network characteristics of the two groups-mpox-positive (mpox-P) and mpox-negative (mpox-N) egos-using χ
2 , t-test and Wilcoxon test to examine the differences between the two groups in each section. Finally, we conducted univariable and multivariable logistic regressions to determine the factors associated with mpox infection., Results: Among the 105 participants, 35 (33.3%) were mpox-P. Compared with mpox-N, mpox-P respondents more frequently reported syphilis (mpox-P: 31.4%; mpox-N: 12.9%) and HIV (mpox-P: 45.7%; mpox-N: 18.6%), and mpox-P individuals to have had at least one sexual contact with a confirmed mpox case (mpox-P: 62.5%; mpox-N: 8.3%). In the egocentric network analysis, mpox-P respondents had a higher prevalence of group sex with alters (mpox-P: 18.5%; mpox-N: 8.9%) and one-time sexual partners (mpox-P: 46.1%; mpox-N: 31.7%). Multivariable logistic regressions showed that reporting stranger/client ties (adjusted OR (aOR)=10.3, 95% CI 1.39 to 76.6) with alters, being vaccinated for mpox (aOR=0.07, 95% CI 0.02 to 0.24) and tie strength heterogeneity (aOR=0.01, 95% CI 0.00 to 0.42) were associated with mpox infection., Conclusions: Our findings highlight the role of demographic, epidemiological and sexual network characteristics in the transmission of mpox virus during the outbreak in Spain. These findings have important implications for future prevention efforts., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)- Published
- 2023
- Full Text
- View/download PDF
193. Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study.
- Author
-
Tantalo LC, Lieberman NAP, Pérez-Mañá C, Suñer C, Vall Mayans M, Ubals M, González-Beiras C, Rodríguez-Gascón A, Canut A, González-Candelas F, Mueller J, Tapia K, Greninger AL, Giacani L, and Mitjà O
- Subjects
- Animals, Infant, Newborn, Humans, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Azithromycin pharmacology, Azithromycin therapeutic use, Macrolides pharmacology, Macrolides therapeutic use, Linezolid pharmacology, Linezolid therapeutic use, Ceftriaxone pharmacology, Ceftriaxone therapeutic use, Globus Pallidus, Drug Resistance, Bacterial genetics, Amoxicillin pharmacology, Amoxicillin therapeutic use, Treponema, Treponema pallidum genetics, Syphilis drug therapy, Syphilis epidemiology, Syphilis microbiology
- Abstract
Background: The increasing incidence of syphilis and the limitations of first-line treatment with penicillin, particularly in neurosyphilis, neonatal syphilis, and pregnancy, highlight the need to expand the therapeutic repertoire for effective management of this disease. We assessed the in-vitro efficacy of 18 antibiotics from several classes on Treponema pallidum subspecies pallidum (T pallidum), the syphilis bacteria., Methods: Using the in-vitro culture system for T pallidum, we exposed the pathogen to a concentration range of each tested antibiotic. After a 7-day incubation, the treponemal burden was evaluated by quantitative PCR targeting the T pallidum tp0574 gene. The primary outcome was the minimum inhibitory concentration (MIC) at which the quantitative PCR values were not significantly higher than the inoculum wells. We also investigated the susceptibility of macrolide-resistant strains to high concentrations of azithromycin, and the possibility of developing resistance to linezolid, a proposed candidate for syphilis treatment., Findings: Amoxicillin, ceftriaxone, several oral cephalosporins, tedizolid, and dalbavancin exhibited anti-treponemal activity at concentrations achievable in human plasma following regular dosing regimens. The experiments revealed a MIC for amoxicillin at 0·02 mg/L, ceftriaxone at 0·0025 mg/L, cephalexin at 0·25 mg/L, cefetamet and cefixime at 0·0313 mg/L, cefuroxime at 0·0156 mg/L, tedizolid at 0·0625 mg/L, spectinomycin at 0·1 mg/L, and dalbavancin at 0·125 mg/L. The MIC for zoliflodacin and balofloxacin was 2 mg/L. Ertapenem, isoniazid, pyrazinamide, and metronidazole had either a poor or no effect. Azithromycin concentrations up to 2 mg/L (64 times the MIC) were ineffective against strains carrying mutations associated to macrolide resistance. Exposure to subtherapeutic doses of linezolid for 10 weeks did not induce phenotypic or genotypic resistance., Interpretation: Cephalosporins and oxazolidinones are potential candidates for expanding the current therapeutic repertoire for syphilis. Our findings warrant testing efficacy in animal models and, if successful, clinical assessment of efficacy., Funding: European Research Council., Competing Interests: Declaration of interests We declare no competing interests., (Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
194. A cross-sectional study to ascertain malaria prevalence among asymptomatic travellers arriving on the Lihir Group of Islands, Papua New Guinea: implications for elimination efforts.
- Author
-
Millat-Martínez P, Baro B, Kasian B, Lorry L, Sanz S, Wali C, Raulo S, Elizah A, Koleala T, Kaius-Ome M, Karl S, Mitjà O, Laman M, Pomat W, and Bassat Q
- Subjects
- Humans, Male, Adult, Female, Papua New Guinea epidemiology, Cross-Sectional Studies, Prevalence, Plasmodium falciparum, Malaria, Falciparum epidemiology, Malaria epidemiology, Malaria prevention & control
- Abstract
Background: The Lihir Islands of Papua New Guinea host a mining operation that has resulted in a mine-impacted zone (MIZ) with reduced malaria transmission and a substantial influx of mine employees, informal cross-country traders, returning locals, and visitors. Prevalence of malaria parasites was assessed in travellers arriving on the Lihir Group of Islands to evaluate the risk of parasite importation., Methods: In 2018, a cross-sectional study at the airport and main wharf was conducted, targeting asymptomatic travellers who had been away from Lihir for at least 12 days. Microscopy, rapid diagnostic tests (RDTs), and quantitative PCR (qPCR) were used to determine Plasmodium parasite prevalence, employing logistic regression models to identify factors associated with qPCR positivity., Results: 398 travellers arriving by plane and 402 arriving by boat were included. Both cohorts were significantly different. Mean age among travellers arriving by plane was 40.1 years (SD ± 10.1), 93% were male and 96% were employed at the mine. In contrast, among travellers arriving by boat, the mean age was 31.7 years (SD ± 14.0), 68% were male and 36% were employed at the mine. The prevalence of malaria infection among travellers arriving by plane was 1% by RDT and microscopy, and increased to 5% by qPCR. In contrast, those arriving by boat showed a prevalence of 8% by RDT and microscopy, and 17% by qPCR. Risk factors for infection were arriving by boat (OR 4.2; 95%CI 2.45,7.21), arriving from nearby provinces with high malaria incidence (OR 5.02; 95%CI 1.80, 14.01), and having been away from Lihir for 91 days or more (OR 4.15; 95%CI 2.58, 6.66). Being mine worker staying at the mine accommodation was related with less infection risk (OR 0.24; 95% CI 0.14, 0.43); while Lihirian residents returning from a trip, VFRs, or people with trading unrelated to mining had higher risks (p = 0.0066)., Conclusions: Travellers arriving by boat faced increased risk of malaria infection than those arriving by plane. This subpopulation poses an import risk to the MIZ and the rest of Lihir Islands. Screening of high-risk groups at wharfs, and collaboration with nearby Islands, could sustain reduced transmission and facilitate malaria elimination strategies., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
195. Classifying necrotising mpox as an AIDS-defining condition.
- Author
-
Mitjà O, Paredes R, Cabtree B, and Orkin C
- Subjects
- Humans, Acquired Immunodeficiency Syndrome, Mpox (monkeypox)
- Published
- 2023
- Full Text
- View/download PDF
196. Epidemiology and determinants of reemerging bacterial sexually transmitted infections (STIs) and emerging STIs in Europe.
- Author
-
Mitjà O, Padovese V, Folch C, Rossoni I, Marks M, Rodríguez I Arias MA, Telenti A, Ciuffi A, Blondeel K, Mårdh O, and Casabona J
- Abstract
In this scoping review, we offer a comprehensive understanding of the current and recent epidemiology, challenges, and emerging issues related to bacterial sexually transmitted infections (STIs) in the WHO European Region. We endeavour in collating data from both EU/EEA and non- EU/EEA countries, thereby giving a complete picture of the region which highlights the higher notification rates in Northern and Western countries than other regions, likely due to differences in testing, access to testing, and surveillance capacity. We provide an up-to-date review on the current knowledge of determinants and persistent inequities in key populations as well as the use of molecular epidemiology for identifying transmission networks in gonorrhoea and syphilis, and detecting chlamydia mutations that evade molecular diagnosis. Finally, we explore the emerging STIs in the region and the evolving transmission routes of food and waterborne diseases into sexual transmission. Our findings call for harmonized STI surveillance systems, proactive strategies, and policies to address social factors, and staying vigilant for emerging STIs., Competing Interests: The authors declare no competing interests., (© 2023 Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
197. Treatment of bacterial sexually transmitted infections in Europe: gonorrhoea, Mycoplasma genitalium , and syphilis.
- Author
-
Mitjà O, Suñer C, Giacani L, Vall-Mayans M, Tiplica GS, Ross JDC, and Bradshaw CS
- Abstract
This review explores the therapeutic challenges of sexually transmitted infections (STI) in Europe, which include increasing antimicrobial resistance and limited progress in drug discovery. We primarily focus on gonorrhoea, Mycoplasma genitalium , and syphilis infections. For gonorrhoea with escalating resistance rates we explore the possibility of combining ceftriaxone with another antibiotic or using alternative antibiotics to mitigate resistance emergence, and we provide insights on the ongoing evaluation of new antimicrobials, like gepotidacin and zoliflodacin. In the case of M. genitalium, which exhibits high resistance rates to first and second-line treatments, we emphasize the importance of resistance-guided therapy in regions with elevated resistance levels, and highlight the limited alternative options, such as pristinamycin and minocycline. Furthermore, we address the challenges posed by syphilis, where the primary treatment consists of penicillin or doxycycline, with challenges arising in neurosyphilis, allergy, pregnancy, and supply shortages and discuss the ongoing evaluation of alternative antimicrobials (e.g., ceftriaxone, cefixime, linezolid). Our findings identify priority actions and provide concrete solutions for long-term effective management of STIs and antimicrobial resistance mitigation., Competing Interests: JR reports personal fees from GSK Pharma and Bayer Consumer Care; ownership of shares in GSK Pharma and AstraZeneca Pharma; lead author of the UK and European Guidelines on Pelvic Inflammatory Disease; Member of the European Sexually Transmitted Infections Guidelines Editorial Board. He is treasurer for the International Union against Sexually Transmitted Infections and chair of charity trustees for the Sexually Transmitted Infections Research Foundation charity. CB reports to be recipient of Federal research funding support from Australian NHMRC (L1 Investigator grant) and the ARC (ARC Industrial Research Transformation Hub), payment of honoraria for drafting of guidelines from Abbott, and receipt of equipment from Speedx and Cepheid. She is a board member of ISSTDR. The other authors declare no competing interests., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
198. Syphilis vaccine: challenges, controversies and opportunities.
- Author
-
Ávila-Nieto C, Pedreño-López N, Mitjà O, Clotet B, Blanco J, and Carrillo J
- Subjects
- Animals, Humans, Rabbits, Treponema pallidum, Immunity, Bacterial Vaccines therapeutic use, Syphilis epidemiology, Syphilis prevention & control
- Abstract
Syphilis is a sexually or vertically (mother to fetus) transmitted disease caused by the infection of Treponema pallidum subspecie pallidum (TPA). The incidence of syphilis has increased over the past years despite the fact that this bacterium is an obligate human pathogen, the infection route is well known, and the disease can be successfully treated with penicillin. As complementary measures to preventive campaigns and early treatment of infected individuals, development of a syphilis vaccine may be crucial for controlling disease spread and/or severity, particularly in countries where the effectiveness of the aforementioned measures is limited. In the last century, several vaccine prototypes have been tested in preclinical studies, mainly in rabbits. While none of them provided protection against infection, some prototypes prevented bacteria from disseminating to distal organs, attenuated lesion development, and accelerated their healing. In spite of these promising results, there is still some controversy regarding the identification of vaccine candidates and the characteristics of a syphilis-protective immune response. In this review, we describe what is known about TPA immune response, and the main mechanisms used by this pathogen to evade it. Moreover, we emphasize the importance of integrating this knowledge, in conjunction with the characterization of outer membrane proteins (OMPs), to expedite the development of a syphilis vaccine that can protect against TPA infection., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Ávila-Nieto, Pedreño-López, Mitjà, Clotet, Blanco and Carrillo.)
- Published
- 2023
- Full Text
- View/download PDF
199. Evaluating the Accuracy of Self-Collected Swabs for the Diagnosis of Mpox.
- Author
-
Ubals M, Tarín-Vicente EJ, Oller X, Mendoza A, Alemany A, Hernández-Rodríguez Á, Casañ C, Rivero Á, Coll P, Cabrera JM, Vall M, Agud-Dios M, Gil-Cruz E, Paris de Leon A, Marinero AR, Folgueira MD, Meléndez MÁ, Buhiichyk V, Galván-Casas C, Paredes R, Prat N, Sala Farré MR, Bonet-Simó JM, Ortiz-Romero PL, Clotet B, Cardona PJ, Blanco I, Marks M, Suñer C, and Mitjà O
- Subjects
- Humans, Female, Oropharynx, Vaginal Smears, Mpox (monkeypox)
- Abstract
We evaluated the accuracy of patient-collected skin lesions, oropharyngeal, and rectal swabs among 50 individuals enrolled in a study of mpox viral dynamics. We found that the performance of self-collected samples was similar to that of physician-collected samples, suggesting that self-sampling is a reliable strategy for diagnosing mpox., Competing Interests: Potential conflicts of interest. M. V. reports support for attending meetings and/or travel for AIMID 2022 (Oviedo, Spain), paid to the author. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
200. Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain.
- Author
-
Suñer C, Ubals M, Tarín-Vicente EJ, Mendoza A, Alemany A, Hernández-Rodríguez Á, Casañ C, Descalzo V, Ouchi D, Marc A, Rivero À, Coll P, Oller X, Miguel Cabrera J, Vall-Mayans M, Dolores Folgueira M, Ángeles Melendez M, Agud-Dios M, Gil-Cruz E, Paris de Leon A, Ramírez Marinero A, Buhiichyk V, Galván-Casas C, Paredes R, Prat N, Sala Farre MR, Bonet-Simó JM, Farré M, Ortiz-Romero PL, Clotet B, García-Patos V, Casabona J, Guedj J, Cardona PJ, Blanco I, Marks M, and Mitjà O
- Subjects
- Male, Humans, Female, Adult, Middle Aged, Prospective Studies, Spain epidemiology, Semen, Saliva, Viral Load, Mpox (monkeypox)
- Abstract
Background: Monkeypox DNA has been detected in skin lesions, saliva, oropharynx, urine, semen, and stool of patients infected during the 2022 clade IIb outbreak; however, the viral dynamics within these compartments remain unknown. We aimed to characterise the viral load kinetics over time in various parts of the body., Methods: This was an observational, prospective, multicentre study of outpatients diagnosed with monkeypox in two hospitals and two sexual health clinics in Spain between June 28, 2022, and Sept 22, 2022. Men and women aged over 18 years were eligible if they reported having symptom onset within the previous 10 days of presentation, and were ineligible if disease was severe enough to be admitted to hospital. Samples were collected from five body locations (skin lesions, oropharynx, rectum, semen or vagina, and a dried blood spot) at six time points up to 57 days after the screening visit. Samples were analysed by quantitative PCR and a subset by cell culture. The primary endpoint was time from symptom onset to viral DNA clearance., Findings: Overall, 1663 samples were collected from 77 study participants. 75 (97%) participants were men, the median age was 35·0 years (IQR 29·0-46·0), and 39 (51%) participants were living with HIV. The median time from symptom onset to viral clearance was 25 days (95% CI 23-28) in the skin lesions, 16 days (13-19) in the oropharynx, 16 days (13-23) in the rectum, 13 days in semen (9-18), and 1 day in blood (0-5). The time from symptom onset to viral clearance for 90% of cases was 41 days (95% CI 34-47) in skin lesions and 39 days (27-56) in semen. The median viral load in skin lesions was 7·3 log
10 copies per mL (IQR 6·5-8·2) at baseline, compared with 4·6 log10 copies per mL (2·9-5·8) in oropharyngeal samples, 5·0 log10 copies per mL (2·9-7·5) in rectal samples, 3·5 log10 copies per mL (2·9-4·7) in semen samples, and 4·0 log10 copies per mL (4·0-4·0) in blood specimens. Replication-competent viruses were isolated in samples with high DNA levels (>6·5 log10 copies per mL)., Interpretation: In immunocompetent patients with mild monkeypox disease, PCR data alone would suggest a contact isolation period of 3 to 6 weeks but, based on detection of replication-competent virus, this time could be reduced. Based on findings from this cohort of patients, semen testing and prolonged use of condoms after recovery from monkeypox might not be necessary., Funding: University Hospital Germans Trias i Pujol and the YoMeCorono., Translation: For the Spanish translation of the abstract see Supplementary Materials section., Competing Interests: Declaration of interests We declare no competing interests., (Copyright © 2023 Elsevier Ltd. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.